<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://www.joseph.larmarange.net/spip.php?id_mot=149&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://www.joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="fr">
		<title>&#201;couter les paires &#233;ducatrices&#160;: la force du savoir exp&#233;rientiel Les paires &#233;ducatrices jouent </title>
		<link>https://www.joseph.larmarange.net/ecouter-les-paires-educatrices-la</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/ecouter-les-paires-educatrices-la</guid>
		<dc:date>2026-02-11T11:05:50Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Paires-&#233;ducatrices &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; Pairs-&#233;ducateurs</dc:subject>

		<description>
&lt;p&gt;Joseph Larmarange &#233;change avec les paires &#233;ducatrices du projet PRINCESSE en C&#244;te d'Ivoire sur les difficult&#233;s de terrain dans la mise en &#339;uvre. &lt;br class='autobr' /&gt; Ici, je discute avec une partie des douze paires &#233;ducatrices du projet Princesse, lors d'un atelier de r&#233;flexion collective. Hors champ se trouve le reste de l'&#233;quipe scientifique qui participe &#233;galement &#224; cet &#233;change. Et derri&#232;re nous, un mur couvert de post-it&#160;: bleu pour ce qui fonctionne, rose pour ce qui coince, jaune pour ce qu'il faut&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-paires-educatrices-pairs-+" rel="tag"&gt;Paires-&#233;ducatrices &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; Pairs-&#233;ducateurs&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH56/img-20230119-wa0003-e85a4.png?1770807953' class='spip_logo spip_logo_right' width='150' height='56' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Joseph Larmarange &#233;change avec les paires &#233;ducatrices du projet PRINCESSE en C&#244;te d'Ivoire sur les difficult&#233;s de terrain dans la mise en &#339;uvre.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;Ici, je discute avec une partie des douze paires &#233;ducatrices du projet Princesse, lors d'un atelier de r&#233;flexion collective. Hors champ se trouve le reste de l'&#233;quipe scientifique qui participe &#233;galement &#224; cet &#233;change. Et derri&#232;re nous, un mur couvert de post-it&#160;: bleu pour ce qui fonctionne, rose pour ce qui coince, jaune pour ce qu'il faut am&#233;liorer. Ce sont leurs mots, leurs exp&#233;riences, leurs analyses critiques, et c'est pr&#233;cis&#233;ment pour cela qu'ils comptent.&lt;/p&gt;
&lt;p&gt;Le projet Princesse s'appuyait sur une clinique mobile de sant&#233; sexuelle qui se d&#233;pla&#231;ait directement sur les sites de prostitution de la r&#233;gion de San-Pedro, en C&#244;te d'Ivoire. Pour le mener &#224; bien, nous avons collabor&#233; avec l'ONG Aprosam et une &#233;quipe m&#234;lant m&#233;decins, biologistes, assistantes sociales&#8230; et paires &#233;ducatrices. Ces derni&#232;res ne sont pas de simples b&#233;n&#233;ficiaires&#160;: elles viennent de la communaut&#233; concern&#233;e et en sont des actrices essentielles. Elles connaissent les r&#233;alit&#233;s du terrain mieux que quiconque, et leurs retours compl&#232;tent ce que nous, chercheurs et soignants, ne percevons pas toujours.&lt;/p&gt;
&lt;p&gt;Leur r&#244;le est d&#233;terminant&#160;: elles recrutent les participantes, les sensibilisent &#224; des outils comme la PrEP orale, les mobilisent pour qu'elles se rendent au camion Princesse et assurent un suivi afin que leur parcours de soins s'inscrive dans la dur&#233;e. Elles nous expliquent aussi, lors d'ateliers comme celui-ci, les obstacles &#224; l'adh&#233;sion au projet ou &#224; la PrEP orale, ce qui est indispensable. En effet, en tant que scientifiques, nous sommes souvent convaincus de la pertinence des solutions propos&#233;es. Mais seule la r&#233;alit&#233; de terrain nous permet de r&#233;aliser que leur adoption n'a rien d'automatique. Le savoir exp&#233;rientiel des paires &#233;ducatrices est alors pr&#233;cieux et essentiels pour mieux comprendre les logiques &#224; l'&#339;uvre.&lt;/p&gt;
&lt;p&gt;C'est gr&#226;ce &#224; elles, par exemple, que nous avons compris pourquoi la prise de PrEP orale n'est pas si simple&#160;: ce n'est pas toujours la priorit&#233; des participantes, qui doivent d'abord, dans un contexte de forte pr&#233;carit&#233;, g&#233;rer d'autres priorit&#233;s quotidiennes. Les contraintes concr&#232;tes de l'offre de pr&#233;vention ne contrebalancent pas forc&#233;ment un b&#233;n&#233;fice plus &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;th&#233;oriques&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;.&lt;/p&gt;
&lt;p&gt;Les retours des paires-&#233;ducatrices nous ont permis d'ajuster l'offre de soins. Par exemple, elles nous ont alert&#233;s sur des aspects tr&#232;s concrets, comme la n&#233;cessit&#233; d'offrir une collation apr&#232;s les consultations comportant de nombreuses prises de sang. Nous pensions qu'un acc&#232;s gratuit aux examens et aux soins suffirait, mais certaines femmes avaient le sentiment d'&#234;tre flou&#233;es&#160;: lorsqu'elles donnent leur sang ailleurs, on leur offre toujours quelque chose &#224; boire ou &#224; manger. Un d&#233;tail simple, pourtant essentiel. D'autres ateliers ont enfin permis de repenser les horaires, de d&#233;placer certains sites d'intervention ou de r&#233;organiser des &#233;tapes du parcours de soins.&lt;/p&gt;
&lt;p&gt;Obtenir des retours sinc&#232;res n'a cependant pas &#233;t&#233; imm&#233;diat. Le contexte joue un r&#244;le important&#160;: les messages des bailleurs p&#232;sent fortement sur les programmes, et le rapport de domination entre savoir scientifique reconnu et savoir exp&#233;rientiel des paires &#233;ducatrices ne doit pas &#234;tre n&#233;glig&#233;. Il nous a alors fallu du temps pour instaurer une relation de confiance, un espace o&#249; les paires &#233;ducatrices se sentent l&#233;gitimes pour d&#233;passer les discours attendus et exprimer leur v&#233;ritable opinion. Nos ateliers en commun ont &#233;t&#233; peu productifs au d&#233;part, mais absolument n&#233;cessaires pour la suite.&lt;/p&gt;
&lt;p&gt;Et la suite, c'est un travail de coconstruction des interventions, o&#249; savoir scientifique et savoir exp&#233;rientiel se r&#233;pondent pour identifier les leviers et les freins &#224; l'adoption de nouveaux outils, et adapter les solutions au mieux. Les communaut&#233;s connaissent leur terrain mieux que nous, chercheurs, qui ne sommes pas sur place en permanence. &#201;couter les premi&#232;res concern&#233;es est donc indispensable. L'empouvoirement prend du temps, mais rien ne peut se faire sans les paires &#233;ducatrices. Leur parole est notre boussole.&lt;/p&gt;
&lt;p&gt;Un grand merci aux paires &#233;ducatrices du projet Princesse&#160;: C&#233;c&#233;, Chef d'&#233;tat-major, Dodo, Flore, Francas, Kiki, Mama Kate, Merveille, Miss Falone, Nemy, Roky et Sly.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Auteur&#160;:&lt;/strong&gt; Louise Hurel &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;strong&gt;Photo&#160;:&lt;/strong&gt; projet PRINCESSE&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;POUR ALLER PLUS LOIN&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Les le&#231;ons du projet PRINCESSE racont&#233;es par les paires-&#233;ducatrices, l'&#233;quipe soignante et l'&#233;quipe scientifique du projet&#160;:&lt;/p&gt;
&lt;div class=&#034;spip_document_ spip_document spip_documents spip_document_video ressource oembed oembed_video oembed_video oembed_youtube&#034; &gt; &lt;figure class=&#034;spip_doc_inner&#034;&gt; &lt;div class=&#034;oembed oe-video async clearfix&#034; style=&#034;max-width:800px;&#034;&gt; &lt;div class=&#034;rwd-video-container oe-play-button&#034; style=&#034;width:100%;height:0;padding-bottom:56.25%;background-image:url('https://i.ytimg.com/vi/Wy6TdjTfSiE/hqdefault.jpg');background-repeat:no-repeat;background-position:center;background-size:cover;&#034; data-content=&#034;%3Ciframe%20width%3D%22800%22%20height%3D%22450%22%20src%3D%22https%3A%2F%2Fwww.youtube-nocookie.com%2Fembed%2FWy6TdjTfSiE%3Ffeature%3Doembed%26autoplay%3D1%22%20frameborder%3D%220%22%20allow%3D%22accelerometer%3B%20autoplay%3B%20clipboard-write%3B%20encrypted-media%3B%20gyroscope%3B%20picture-in-picture%3B%20web-share%22%20referrerpolicy%3D%22strict-origin-when-cross-origin%22%20allowfullscreen%20title%3D%22Le%C3%A7ons%20apprises%20du%20projet%20ANRS%2012381%20PRINCESSE%20en%20C%C3%B4te%20d%E2%80%99Ivoire%22%3E%3C%2Fiframe%3E&#034;&gt; &lt;button&gt;&lt;span class=&#034;oe-play-button_label&#034;&gt;Lecture&lt;/span&gt;&lt;/button&gt; &lt;/div&gt; &lt;style&gt;&lt;!--/**/.oe-video .loading {background-image:url(&#034;prive/themes/spip/images/searching.gif&#034;)!important;background-size:auto !important;}/**/--&gt;&lt;/style&gt;
&lt;/div&gt; &lt;figcaption class=&#034;spip_doc_legende&#034;&gt;
&lt;div class=&#034;spip_doc_titre&#034; style=&#034;max-width:800px;&#034;&gt;&lt;a href=&#034;https://youtu.be/Wy6TdjTfSiE&#034; class=&#034;oe-title&#034;&gt;Le&#231;ons apprises du projet ANRS 12381 PRINCESSE en C&#244;te d'Ivoire&lt;/a&gt; &lt;span class=&#034;oe-author&#034;&gt;&lt;br/&gt;&lt;span class=&#034;oe-author_par&#034;&gt;par &lt;/span&gt;&lt;a href=&#034;https://www.youtube.com/@Ceped&#034; class=&#034;oe-author_name&#034;&gt;Ceped - Centre Population &amp; D&#233;veloppement&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&#034;spip_doc_titre oembed-source&#034;&gt;&lt;a href=&#034;https://youtu.be/Wy6TdjTfSiE&#034; class=&#034;spip_url spip_out&#034; rel=&#034;external&#034;&gt;https://youtu.be/Wy6TdjTfSiE&lt;/a&gt;
&lt;/div&gt;
&lt;/figcaption&gt; &lt;script&gt;jQuery(function(){ jQuery('.oembed.oe-video.async').not('.done').addClass('done').on('click', '.oe-play-button',function(e){var $me = jQuery(this),content = decodeURIComponent($me.data('content'));$me.removeClass('oe-play-button').addClass('loading').html(content);})})&lt;/script&gt; &lt;/figure&gt;
&lt;/div&gt;
&lt;p&gt;&lt;strong&gt;ANNEXE&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Le projet PRINCESSE a &#233;t&#233; financ&#233; par l'ANRS|MIE. Il a &#233;t&#233; coordonn&#233; par le programme PAC-CI en C&#244;te d'Ivoire et l'IRD en France et a impliqu&#233; de nombreux partenaires institutionnels. Plus d'informations sur &lt;a href=&#034;https://www.ceped.org/princesse&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://www.ceped.org/princesse&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters</title>
		<link>https://www.joseph.larmarange.net/adoption-of-hiv-preexposure</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/adoption-of-hiv-preexposure</guid>
		<dc:date>2025-07-15T15:10:30Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, M&#233;lanie Plazy, Marcellin Nouaman, Evelyne Kissi, Rose-Marcelle Dedocoton, Patrick Coffie, Serge Eholi&#233;, Valentine Becquet &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
BACKGROUND: The ANRS 12381 PRINCESSE project (11/2019-06/2023) enrolled 489 FSWs and implemented community-based sexual and reproductive health care, including PrEP, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L86xH150/ias2025-a9891.png?1752596042' class='spip_logo spip_logo_right' width='86' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163756&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163730v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-1a4ce10f-3d2ff.png?1752686173' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, International AIDS Society, Jul 2025, Kigali, Rwanda&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163730&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, M&#233;lanie Plazy, Marcellin Nouaman, Evelyne Kissi, Rose-Marcelle Dedocoton, Patrick Coffie, Serge Eholi&#233;, Valentine Becquet&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;BACKGROUND:&lt;/strong&gt; The ANRS 12381 PRINCESSE project (11/2019-06/2023) enrolled 489 FSWs and implemented community-based sexual and reproductive health care, including PrEP, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with its use, focusing on &#8220;early adopters&#8221;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;METHODS:&lt;/strong&gt; This analysis included 400 FSWs eligible for PrEP (HIV-negative, HBsAg-negative) enrolled up to December 2022 (&gt;6 months of follow-up). Clinical records were analyzed to describe PrEP cascade, follow-up, and PrEP trajectories. A multivariable logistic regression identified factors associated with PrEP early adopters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; Although 98% of eligible FSWs were interested in PrEP, only 62% initiated PrEP, and 39% renewed it at least once.&lt;br class='autobr' /&gt;
Follow-up was very short (&lt;6 months) for 48%, short (6-12 months) for 15%, seasonal (&gt;12 months with a gap of 6 months between two visits) for 31%, and regular (&gt;12 months with no gap) for 6%.&lt;br class='autobr' /&gt;
PrEP initiation was high among FSWs with regular (96%), seasonal (83%), or short (80%) follow-up, vs. 39% for those with very short follow-up. Among those who initiated, only 88% (regular), 70% (seasonal), 74% (short), and 35% (very short) renewed PrEP.&lt;br class='autobr' /&gt;
Among 148 FSWs with regular/seasonal follow-up, four PrEP trajectories were identified (cf. figure showing individual trajectories): 15% &#8220;never initiated&#8221; PrEP, 39% &#8220;initiated and were later not interested anymore&#8221;, 18% &#8220;re-initiated after non-interest&#8221;, and 28% &#8220;initiated and never expressed non-interest&#8221;, the last two groups being considered as &#8220;early adopters&#8221;. Factors associated with early PrEP adoption included the usual price of intercourse with clients &lt;1500 FCFA (aOR=2.4 [1.2-4.8]) and working in brothels (aOR=3.2 [1.6-6.6]).&lt;/p&gt;
&lt;dl class='spip_document_627 spip_documents spip_documents_center media media_vignette'&gt; &lt;dt&gt;&lt;a href='https://www.joseph.larmarange.net/IMG/png/figure_1000.png' class=&#034;spip_in&#034; title=&#034;Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project&#034; hreflang=&#034;&#034; type=&#034;image/png&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L240xH360/figure_1000-140af-7601a.png?1752596042' width='240' height='360' alt='Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project' /&gt;&lt;/a&gt;&lt;/dt&gt; &lt;dt class='spip_doc_titre crayon document-titre-627' style='max-width: 240px;'&gt;&lt;strong&gt;Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project&lt;/strong&gt;&lt;/dt&gt;&lt;/dl&gt;
&lt;p&gt;&lt;strong&gt;CONCLUSIONS:&lt;/strong&gt; In PRINCESSE, loss-to-follow-up and seasonality of risks limited PrEP adoption. FSWs who were more precarious and less mobile became early adopters of this new prevention tool and could serve as potential ambassadors for promoting its uptake.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
See also&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163769&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163769v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perceptions regarding long-acting pre-exposure prevention (PrEP) among female sex workers and men having sex with men in San Pedro and Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, Jul 2025, Kigali, Rwanda. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.ias2025.org/Abstract/Abstract/?abstractid=4762&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163769&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Pilot Implementation of HIV Self-Testing Delivery in Private Pharmacies Combined With a Respondent-Driven Sampling Method to Improve HIV Testing for Men Who Have Sex With Men and Transgender Women in Phnom Penh (ANRS 0100s): Protocol for a Prospective Mixed Method Feasibility Study</title>
		<link>https://www.joseph.larmarange.net/pilot-implementation-of-hiv-self-394</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/pilot-implementation-of-hiv-self-394</guid>
		<dc:date>2025-06-27T09:45:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Cambodge</dc:subject>
		<dc:subject>ANRS 0100s</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Recrutement &#171; boules de neige &#187;</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Chhavarath Dary, Olivier S&#233;g&#233;ral, Joseph Larmarange, Emilie Mosnier, Mohamed Ben Mechlia, Vichea Ouk, Bruno Spire, Vonthanak Saphonn &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background: Regular testing is recognized as a key strategy for HIV control. The 2023 Integrated Biological and Behavioral Survey (IBBS) in Cambodia revealed that nearly one-third of men who have sex with men (MSM) and one-fourth of transgender women (TGW) were never tested for HIV or not for more than 12 months. The majority of MSM and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cambodge-+" rel="tag"&gt;Cambodge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ANRS-0100s-+" rel="tag"&gt;ANRS 0100s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171; boules de neige &#187;&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH113/f2e214ec3daa033d346190e8d7b20686-5b34d.png?1769080731' class='spip_logo spip_logo_right' width='150' height='113' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5471400&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://inserm.hal.science/inserm-05471400v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-1c6e23c0-0556d.png?1770301547' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://inserm.hal.science/inserm-05471400v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Pilot Implementation of HIV Self-Testing Delivery in Private Pharmacies Combined With a Respondent-Driven Sampling Method to Improve HIV Testing for Men Who Have Sex With Men and Transgender Women in Phnom Penh (ANRS 0100s): Protocol for a Prospective Mixed Method Feasibility Study&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731409800&#034; class=&#034;hal-auteur&#034;&gt;Chhavarath Dary&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731409801&#034; class=&#034;hal-auteur&#034;&gt;Olivier S&#233;g&#233;ral&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/emilie-mosnier&#034; class=&#034;hal-auteur&#034;&gt;Emilie Mosnier&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731636730&#034; class=&#034;hal-auteur&#034;&gt;Mohamed Ben Mechlia&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731636731&#034; class=&#034;hal-auteur&#034;&gt;Vichea Ouk&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/bruno-spire&#034; class=&#034;hal-auteur&#034;&gt;Bruno Spire&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731522455&#034; class=&#034;hal-auteur&#034;&gt;Vonthanak Saphonn&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;JMIR Research Protocols&lt;/i&gt;, 2025, 14, pp.e65351. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.2196/65351&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.2196/65351&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://inserm.hal.science/inserm-05471400v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;inserm-05471400&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Chhavarath Dary, Olivier S&#233;g&#233;ral, Joseph Larmarange, Emilie Mosnier, Mohamed Ben Mechlia, Vichea Ouk, Bruno Spire, Vonthanak Saphonn&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Regular testing is recognized as a key strategy for HIV control. The 2023 Integrated Biological and Behavioral Survey (IBBS) in Cambodia revealed that nearly one-third of men who have sex with men (MSM) and one-fourth of transgender women (TGW) were never tested for HIV or not for more than 12 months. The majority of MSM and TGW were tested at community-based organizations (CBOs) facilities and by CBO outreach workers, while private facilities are poorly used for HIV testing (6% for MSM and 9% for TGW). Private pharmacies could be able to deliver HIV self-testing kits giving the advantage of confidentiality, anonymity, and time savings, in particular for those reluctant to visit CBOs. The recruitment of participants using a respondent-driven sampling method could provide the opportunity to reach MSM and TGW outside the network of CBOs.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Objective:&lt;/strong&gt; This pilot study aims to evaluate the feasibility of free HIV self-testing delivery by a private pharmacy combined with a respondent-driven sampling method to improve HIV testing among MSM and TGW in Phnom Penh, Cambodia.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods:&lt;/strong&gt; Both qualitative and quantitative approaches are used in this prospective feasibility study. The protocol was approved by the National Ethics Committee for Health Research in Cambodia (N0 351 NECHR). MSM and TGW aged more than 18 years old will be recruited via a respondent-driven sampling method with seeds recruited at hot spots and on social networks. The seeds will then distribute electronic and paper coupons to their networks physically and via social media, messaging, and calling applications. Each recruited peer will bring the coupon to receive direct and free access to one HIV self-testing kit at partner pharmacies as well as 10 additional coupons to recruit members of their networks. As for quantitative analysis, data from the study website will be imported, appended into a single matrix using Stata version 18SE (StataCorp), and analyzed using descriptive statistics, with a statistical significance level of .05. After 6 months, a qualitative assessment will be conducted among users, providers, and policymakers or key stakeholders to evaluate the acceptability and appropriateness of the strategy and to identify the barriers, facilitators, and recommendations. All transcripts will be analyzed according to the 6-phase reflexive thematic approach by Braun and Clarke. The results will be reported by participant-based and provider-based issues. QSR NVivo V.14 for Windows will be used to manage the data.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; The study was funded by Agence nationale de recherches sur le sida, les h&#233;patites, et les maladies infectieuses &#233;mergentes (ANRS) in September 2023. Approval of the study protocol was successfully obtained from the NECHR in Cambodia and the Commission Nationale de l'Informatique et des Libert&#233;s (CNIL) in France (Autorisation Tacite) in February 2025. Data collection will be conducted between September 2024 and December 2025. The initial results are expected to be published in February 2026.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; This public-private partnership intervention could allow the hidden population of MSM and TGW in Phnom Penh to be reached and tested.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Trial Registration:&lt;/strong&gt; ClinicalTrials.gov NCT05745168; &lt;a href=&#034;https://clinicaltrials.gov/study/NCT05745168&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://clinicaltrials.gov/study/NCT05745168&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Recherche interventionnelle&#160;: transformer des innovations efficaces en interventions efficientes</title>
		<link>https://www.joseph.larmarange.net/recherche-interventionnelle-339</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/recherche-interventionnelle-339</guid>
		<dc:date>2023-03-21T14:44:07Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Communication orale r&#233;alis&#233;e le 21&#160;mars 2023 dans le cadre des Journ&#233;es scientifiques 2023 de l'ANRS&#124;MIE &#224; Paris. &lt;br class='autobr' /&gt; Recherche interventionnelle&#160;: transformer des innovations efficaces en interventions efficiences &lt;br class='autobr' /&gt; Joseph Larmarange Journ&#233;es scientifiques 2023 de l'ANRS | Maladies infectieuses &#233;mergentes, ANRS | MIE, Mar 2023, Paris, France Communication dans un congr&#232;s&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH84/626783_w4900h2756c1cx2450cy1597-b5912.jpg?1715129905' class='spip_logo spip_logo_right' width='150' height='84' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale r&#233;alis&#233;e le 21&#160;mars 2023 dans le cadre des Journ&#233;es scientifiques 2023 de l'&lt;a href=&#034;https://www.anrs.fr/fr&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;ANRS&#124;MIE&lt;/a&gt; &#224; Paris.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4039600&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-04039578v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-da4cabb3-e958e.png?1702920734' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04039578v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Recherche interventionnelle : transformer des innovations efficaces en interventions efficiences&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Journ&#233;es scientifiques 2023 de l'ANRS | Maladies infectieuses &#233;mergentes&lt;/i&gt;, ANRS | MIE, Mar 2023, Paris, France&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04039578v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-04039578&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;figure class='spip_document_504 spip_documents media_pdfjs media_application media_application_pdf'&gt; &lt;!--[if !IE]&gt;&lt;!--&gt;&lt;iframe src=&#034;spip.php?page=pdfjs&amp;id_document=504&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;!--&lt;![endif]--&gt; &lt;!--[if IE]&gt;&lt;iframe src=&#034;IMG/pdf/journees_anrs_larmarange_v2023-03-21.pdf&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;![endif]--&gt; &lt;/figure&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne</title>
		<link>https://www.joseph.larmarange.net/hdr</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/hdr</guid>
		<dc:date>2022-10-14T06:38:12Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>CAP-CoV-Soignants-BF</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>ELIHoS (ANRS 12139)</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Pr&#233;valences du VIH (ANRS 12114)</dc:subject>
		<dc:subject>prevR</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Burkina Faso</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Cartographie</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Comparaison de cohortes</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>
		<dc:subject>Enseignement acad&#233;mique</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>Estimateurs &#224; noyau (kernel density estimation)</dc:subject>
		<dc:subject>Femmes enceintes</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Interpolation spatiale</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Masculinit&#233;s</dc:subject>
		<dc:subject>M&#233;nages</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Observatoire de population</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;valence du VIH</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Structures de sant&#233;</dc:subject>
		<dc:subject>Surveillance sentinelle</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Temporalit&#233;s</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;. &lt;br class='autobr' /&gt; D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne &lt;br class='autobr' /&gt; Joseph Larmarange D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022 HDR tel-03814024&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-CAP-CoV-Soignants-BF-+" rel="tag"&gt;CAP-CoV-Soignants-BF&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ELIHoS-ANRS-12139-+" rel="tag"&gt;ELIHoS (ANRS 12139)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevalences-du-VIH-ANRS-12114-+" rel="tag"&gt;Pr&#233;valences du VIH (ANRS 12114)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-prevR-+" rel="tag"&gt;prevR&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Burkina-Faso-+" rel="tag"&gt;Burkina Faso&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cartographie-+" rel="tag"&gt;Cartographie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comparaison-de-cohortes-+" rel="tag"&gt;Comparaison de cohortes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-EDS-Enquetes-Demographiques-et-de-+" rel="tag"&gt;EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Enseignement-academique-+" rel="tag"&gt;Enseignement acad&#233;mique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Estimateurs-a-noyau-kernel-density-+" rel="tag"&gt;Estimateurs &#224; noyau (kernel density estimation)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Femmes-enceintes-+" rel="tag"&gt;Femmes enceintes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Interpolation-spatiale-+" rel="tag"&gt;Interpolation spatiale&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Masculinites-+" rel="tag"&gt;Masculinit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Menages-+" rel="tag"&gt;M&#233;nages&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Observatoire-de-population-+" rel="tag"&gt;Observatoire de population&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevalence-du-VIH-+" rel="tag"&gt;Pr&#233;valence du VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structures-de-sante-+" rel="tag"&gt;Structures de sant&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Surveillance-sentinelle-+" rel="tag"&gt;Surveillance sentinelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Temporalites-142-+" rel="tag"&gt;Temporalit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Usagers-de-drogue-par-voie-+" rel="tag"&gt;Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH109/ruban_spirales-a3fec.png?1715097926' class='spip_logo spip_logo_right' width='150' height='109' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3814024&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://theses.hal.science/tel-03814024v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-877a2ad2-17cac.png?1702907846' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;D&#233;crire les &#233;pid&#233;mies, Comprendre les populations : une d&#233;mographie du VIH en Afrique subsaharienne&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-hdr&#034;&gt;HDR&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;tel-03814024&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;500&#034; src=&#034;https://www.youtube.com/embed/me6rDSq0p0k&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;h2 class=&#034;spip&#034;&gt;
Jury&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Didier Breton (Universit&#233; de Strasbourg, rapporteur)&lt;/li&gt;&lt;li&gt; Val&#233;rie Delauney (IRD, rapportrice)&lt;/li&gt;&lt;li&gt; Annabel Desgr&#233;es du Lo&#251; (IRD, garante)&lt;/li&gt;&lt;li&gt; G&#233;raldine Duth&#233; (Ined, rapportrice)&lt;/li&gt;&lt;li&gt; Didier Ekouevi (Inserm, Universit&#233; de Lom&#233;, examinateur)&lt;/li&gt;&lt;li&gt; V&#233;ronique Petit (Universit&#233; Paris Cit&#233;, pr&#233;sidente)&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/hdr_larmarange_v2022-10-12.pdf" length="15224200" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>Atteindre les populations p&#233;riph&#233;riques en Afrique de l'Ouest&#160;: autod&#233;pistage du VIH et distribution secondaire</title>
		<link>https://www.joseph.larmarange.net/Interview-CLiSP-47</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Interview-CLiSP-47</guid>
		<dc:date>2022-06-24T14:30:37Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Interview dans le Bulletin du Coll&#232;ge de Liaison des Internes de Sant&#233; Publique de juin 2022, &#224; l'occasion du Congr&#232;s National des Internes de Sant&#233; Publique. &lt;br class='autobr' /&gt; Propos recueillis par Fabiana Cazzorla (ISP &#224; Grenoble) avec l'aide de B&#233;renger Thomas et Audrey Geoffroy (ISP &#224; Paris). R&#233;f&#233;rence &lt;br class='autobr' /&gt;
Larmarange Joseph (2022) &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Atteindre les populations p&#233;riph&#233;riques en Afrique de l'Ouest&#160;: autod&#233;pistage du VIH et distribution secondaire&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;Fabiana Cazzorla, Bulletin du CLiSP #47.&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH84/clisp-7f588.png?1715097927' class='spip_logo spip_logo_right' width='150' height='84' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Interview dans le &lt;i&gt;Bulletin du Coll&#232;ge de Liaison des Internes de Sant&#233; Publique&lt;/i&gt; de juin 2022, &#224; l'occasion du Congr&#232;s National des Internes de Sant&#233; Publique.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;Propos recueillis par Fabiana Cazzorla (ISP &#224; Grenoble) avec l'aide de B&#233;renger Thomas et Audrey Geoffroy (ISP &#224; Paris).&lt;/p&gt;
&lt;!--[if !IE]&gt;&lt;!--&gt;&lt;iframe src=&#034;spip.php?page=pdfjs&amp;id_document=476&#034; width=&#034;490&#034; height=&#034;600&#034; title=&#034;Interview de Joseph Larmarange dans le bulletin du CLiSP #47&#034; class=&#034;spip_document_476 lecteurpdf lecteufpdf-476 spip_documents&#034; name=&#034;pdf_476&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;!--&lt;![endif]--&gt; &lt;!--[if IE]&gt;&lt;iframe src=&#034;IMG/pdf/bulletin_clips_47_interview_larmarange.pdf&#034; width=&#034;490&#034; height=&#034;600&#034; class=&#034;spip_document_476 lecteurpdf lecteufpdf-476 spip_documents&#034; title=&#034;Interview de Joseph Larmarange dans le bulletin du CLiSP #47&#034; name=&#034;pdf_476&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;![endif]--&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;B98TUEQ8&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2022) &#171;&#160;Atteindre les populations p&#233;riph&#233;riques en Afrique de l'Ouest : autod&#233;pistage du VIH et distribution secondaire&#160;&#187;Fabiana &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Cazzorla&lt;/span&gt;, Bulletin du CLiSP #47. https://clisp.fr/2022/06/22/bulletin-47-juin-2022/.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>La PrEP seule ne suffit pas&#160;: elle doit &#234;tre accompagn&#233;e d'une offre de soins globale</title>
		<link>https://www.joseph.larmarange.net/La-PrEP-seule-ne-suffit-pas-elle</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/La-PrEP-seule-ne-suffit-pas-elle</guid>
		<dc:date>2022-05-19T09:49:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>

		<description>
&lt;p&gt;Cette note de politique, pr&#233;par&#233;e par PAC-CI, repose sur des r&#233;sultats du projet PrEP-CI ANRS 12361. &lt;br class='autobr' /&gt; La PrEP seule ne suffit pas&#160;: elle doit &#234;tre accompagn&#233;e d'une offre de soins globale &lt;br class='autobr' /&gt; Alexandra Bitty-Anderson , Annick Gui&#233; , Eulalie Kanga , Marcellin Nouaman ,&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L100xH150/dsc03314-1d274.jpg?1715146422' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Cette note de politique, pr&#233;par&#233;e par PAC-CI, repose sur des r&#233;sultats du projet &lt;a href='https://www.joseph.larmarange.net/Etude-de-faisabilite-en-vue-d-un' class=&#034;spip_in&#034;&gt;PrEP-CI ANRS 12361&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3882265&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-03882265v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-bb4eaea8-b9e24.png?1702930409' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03882265v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;La PrEP seule ne suffit pas : elle doit &#234;tre accompagn&#233;e d'une offre de soins globale&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Alexandra+Bitty-Anderson&#034; class=&#034;hal-auteur&#034;&gt;Alexandra Bitty-Anderson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Annick+Gui%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Annick Gui&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Eulalie+Kanga&#034; class=&#034;hal-auteur&#034;&gt;Eulalie Kanga&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;Note de politique PAC-CI #3, Programme PAC-CI. 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-report&#034;&gt;Rapport&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03882265v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-03882265&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;figure class='spip_document_457 spip_documents media_pdfjs media_application media_application_pdf'&gt; &lt;!--[if !IE]&gt;&lt;!--&gt;&lt;iframe src=&#034;spip.php?page=pdfjs&amp;id_document=457&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;!--&lt;![endif]--&gt; &lt;!--[if IE]&gt;&lt;iframe src=&#034;IMG/pdf/prep-ci_note_de_politique_prep_et_offre_sante_globale.pdf&#034; width=&#034;100%&#034; height=&#034;600&#034; style=&#034;border: none;&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;![endif]--&gt; &lt;/figure&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Pilot implementation of HIV self-testing delivery in private pharmacies combined to a Respondent Driven Sampling method to improve HIV testing for MSM and TGW in Phnom Penh</title>
		<link>https://www.joseph.larmarange.net/Pilot-implementation-of-HIV-self</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Pilot-implementation-of-HIV-self</guid>
		<dc:date>2022-04-28T16:15:56Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Cambodge</dc:subject>
		<dc:subject>ANRS 0100s</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Responsables scientifiques SAPHONN Vonthanak (University of Health Sciences of Phnom Penh) SPIRE Bruno (SESSTIM) &lt;br class='autobr' /&gt;
Partenariat UMR 1252 Sciences Economiques &amp; Sociales de la Sant&#233; &amp; Traitement de l'Information M&#233;dicale (SESSTIM) University of Health Sciences of Phnom Penh (UHS) Ceped, IRD &lt;br class='autobr' /&gt;
Financement &lt;br class='autobr' /&gt;
ANRS &lt;br class='autobr' /&gt; Abstract &lt;br class='autobr' /&gt;
Primary objective &lt;br class='autobr' /&gt;
Evaluate the feasibility of HIV self-testing (HIVST) delivery by a private pharmacy network among men who have sex with men (MSM) and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cambodge-+" rel="tag"&gt;Cambodge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ANRS-0100s-+" rel="tag"&gt;ANRS 0100s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH101/2016-07-12-1468317337-5848535-menofcambodia2alexbunthaspacehair-80839.jpg?1715143966' class='spip_logo spip_logo_right' width='150' height='101' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4678769&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04678769v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04678769v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Pilot implementation of HIV self-testing delivery in private pharmacies combined to a Respondent Driven Sampling method to improve HIV testing for MSM and TGW in Phnom Penh &#8211; ANRS 0100s: a prospective feasibility study (Preprint)&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731409800&#034; class=&#034;hal-auteur&#034;&gt;Chhavarath Dary&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731409801&#034; class=&#034;hal-auteur&#034;&gt;Olivier S&#233;g&#233;ral&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/emilie-mosnier&#034; class=&#034;hal-auteur&#034;&gt;Emilie Mosnier&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mohamed+Ben+Mechlia&#034; class=&#034;hal-auteur&#034;&gt;Mohamed Ben Mechlia&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Vichea+Ouk&#034; class=&#034;hal-auteur&#034;&gt;Vichea Ouk&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Bruno+Spire&#034; class=&#034;hal-auteur&#034;&gt;Bruno Spire&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Vonthanak+Saphonn&#034; class=&#034;hal-auteur&#034;&gt;Vonthanak Saphonn&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2024&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-undefined&#034;&gt;Pr&#233;-publication, Document de travail&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04678769v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04678769&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsables scientifiques&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; SAPHONN Vonthanak (University of Health Sciences of Phnom Penh)&lt;/li&gt;&lt;li&gt; SPIRE Bruno (SESSTIM)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenariat&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;https://sesstim.univ-amu.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;UMR 1252 Sciences Economiques &amp; Sociales de la Sant&#233; &amp; Traitement de l'Information M&#233;dicale (SESSTIM)&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://www.uhs.edu.kh/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;University of Health Sciences of Phnom Penh (UHS)&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://www.ceped.org&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Ceped, IRD&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financement&lt;/h2&gt;
&lt;p&gt;&lt;a href=&#034;https://anrs.fr/&#034; class=&#034;spip_out&#034; title=&#034;MIE&#034; rel=&#034;external&#034;&gt;ANRS&lt;/a&gt;&lt;/p&gt;
&lt;div lang='en'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Primary objective&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Evaluate the feasibility of HIV self-testing (HIVST) delivery by a private pharmacy network among men who have sex with men (MSM) and transgender women (TGW) recruited through a classic and digital Respondent Driven Sampling method to improve HIV testing in Phnom Penh, Cambodia&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Secondary objectives&lt;/strong&gt;&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Evaluate the acceptability and appropriateness of the strategy&lt;/li&gt;&lt;li&gt; Identify barriers and facilitators&lt;/li&gt;&lt;li&gt; Estimate the linkage to confirmatory testing for those with a reactive test and linkage to HIV care and ART for those with a positive confirmatory HIV test&lt;/li&gt;&lt;li&gt; Estimate linkage to pre-exposure prophylaxis (PrEP) services for negative participants&lt;/li&gt;&lt;li&gt; Estimate the characteristics of participants and compare to those reported in Integrated Biological and Behavioral Survey (IBBS 2019) for MSM and TGW in Cambodia&lt;/li&gt;&lt;li&gt; Evaluate the adherence of participants to a 6-monthly repeated HIV testing&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Methodology&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;An interventional pilot study using a mixed qualitative and quantitative approach will be carried out in order to evaluate the feasibility, acceptability and appropriateness of the strategy and to identify barriers and facilitators.&lt;/p&gt;
&lt;p&gt;The participant recruitment method will be designed as a Respondent Driven Sampling (RDS) by recruiting initial seeds both at hotspots and on social networks. Prior to seed recruitment, a consultative meeting will be conducted in order to optimise the selection criteria of the seeds. The seeds will then distribute electronic and paper coupons to their networks physically and via social media, messaging and calling applications such as Twitter, Whatapp and Telegram (e-coupons). Each recruited participant will bring the coupon to be scanned at partner pharmacies to receive direct and free access to one HIVST kit. Partner pharmacies with a proper dedicated room/space securing privacy and secrecy in Phnom Penh are the study sites. There, trained community workers who get notified by partner at each visit of participant will do the study visit including information/consent, e-CRF filling and give a link of an external website to send the HIV test results and receive information or advices. These recruited individuals will be considered as wave 1 of recruitment and will each receive 10 additional coupons to recruit the members of their networks. The next round of individuals recruited and enrolled will be considered as wave 2, and so on.&lt;/p&gt;
&lt;p&gt;After 6 months, a qualitative assessment via focus groups will be conducted among MSM, TGW and pharmacists to evaluate feasibility, acceptability and appropriateness of the intervention and to identify barriers and facilitators.&lt;/p&gt;
&lt;p&gt;Several ART sites/HIV clinics particularly in charge of key populations will be specifically selected as participating centers in order to collect information on linkage to care or prevention services for positive and negative participants, respectively.&lt;/p&gt;
&lt;p&gt;Each participant will be followed during 18 months and encouraged to perform a 6-monthly HIV testing during this period.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Expected enrolment&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A pragmatic approach is carried out in which the enrolment will be stopped at the end of the inclusion period or if the number of participants reaches a maximum of 1500.&lt;/p&gt;
&lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Zone g&#233;ographique&lt;/h2&gt;
&lt;p&gt;Phnom Penh, Cambodge&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2022-2024&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Au-del&#224; des populations cl&#233;s&#160;: la distribution secondaire de kits d'autod&#233;pistage du VIH en Afrique de l'Ouest</title>
		<link>https://www.joseph.larmarange.net/Au-dela-des-populations-cles-la</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Au-dela-des-populations-cles-la</guid>
		<dc:date>2021-12-09T18:42:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Co&#251;ts</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Ressources &#233;conomiques</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Communication orale dans le cadre du symposium ATLAS qui s'est tenu le 7&#160;d&#233;cembre 2021 dans le cadre de la 21&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence ICASA. &lt;br class='autobr' /&gt; Au-del&#224; des populations cl&#233;s&#160;: la distribution secondaire de kits d'autod&#233;pistage du VIH en Afrique de l'Ouest &lt;br class='autobr' /&gt; Joseph Larmarange 21th ICASA (International Conference on AIDS and STIs in Africa), Society for AIDS in Africa (SAA), Dec 2021, Durban,&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Couts-+" rel="tag"&gt;Co&#251;ts&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Ressources-economiques-+" rel="tag"&gt;Ressources &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH100/arton303-bb012.jpg?1715124947' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale dans le cadre du &lt;i&gt;symposium ATLAS&lt;/i&gt; qui s'est tenu le 7&#160;d&#233;cembre 2021 dans le cadre de la 21&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence ICASA.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4058389&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-04058389v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-8366f2e5-18527.png?1702942077' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04058389v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Au-del&#224; des populations cl&#233;s : la distribution secondaire de kits d'autod&#233;pistage du VIH en Afrique de l'Ouest&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;21th ICASA (International Conference on AIDS and STIs in Africa)&lt;/i&gt;, Society for AIDS in Africa (SAA), Dec 2021, Durban, Afrique du Sud&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04058389v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-04058389&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;450&#034; src=&#034;https://www.youtube-nocookie.com/embed/QTqyNkIIjK0?start=594&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE project</title>
		<link>https://www.joseph.larmarange.net/A-community-based-healthcare</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/A-community-based-healthcare</guid>
		<dc:date>2021-12-06T09:50:35Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Organisation des soins</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Protocol paper of the ANRS 12381 PRINCESSE project. &lt;br class='autobr' /&gt;
Authors &lt;br class='autobr' /&gt;
Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Aline Agoua, Cl&#233;mence Z&#233;bago, Herv&#233; Dao, Alice Montoyo, Aude Jary, Patrick A. Coffie, Serge Eholi&#233;, Joseph Larmarange &amp; and the ANRS 12381 PRINCESSE team &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
Pre-exposure prophylaxis (PrEP) is recommended by the WHO for HIV prevention among female sex workers (FSWs). A study conducted in 2016&#8211;2017 in C&#244;te d'Ivoire showed that if PrEP is acceptable,&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Organisation-des-soins-+" rel="tag"&gt;Organisation des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH112/arton302-9604f.jpg?1763089085' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Protocol paper of the &lt;a href='https://www.joseph.larmarange.net/PRINCESSE-PrEP-infections' class=&#034;spip_in&#034; hreflang=&#034;fr&#034;&gt;ANRS 12381 PRINCESSE project&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3467822&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-03467822v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-e92fcf30-16f53.png?1702910744' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03467822v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE project&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Herv%C3%A9+Dao&#034; class=&#034;hal-auteur&#034;&gt;Herv&#233; Dao&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Alice+Montoyo&#034; class=&#034;hal-auteur&#034;&gt;Alice Montoyo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/aude-jary&#034; class=&#034;hal-auteur&#034;&gt;Aude Jary&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+A.+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick A. Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Eholi%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;BMC Public Health&lt;/i&gt;, 2021, 21 (1), pp.2214. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1186/s12889-021-12235-0&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1186/s12889-021-12235-0&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03467822v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-03467822&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Marcellin Nouaman, M&#233;lanie Plazy, Aline Agoua, Cl&#233;mence Z&#233;bago, Herv&#233; Dao, Alice Montoyo, Aude Jary, Patrick A. Coffie, Serge Eholi&#233;, Joseph Larmarange &amp; and the ANRS 12381 PRINCESSE team&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Pre-exposure prophylaxis (PrEP) is recommended by the WHO for HIV prevention among female sex workers (FSWs). A study conducted in 2016&#8211;2017 in C&#244;te d'Ivoire showed that if PrEP is acceptable, FSWs also have many uncovered sexual health needs. Based on this evidence, the ANRS 12381 PRINCESSE project was developed in collaboration with a community-based organization. The main objective is to develop, document, and analyze a comprehensive sexual and reproductive healthcare package among FSWs in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;PRINCESSE is an open, single-arm interventional cohort of 500 FSWs in San Pedro (C&#244;te d'Ivoire) and its surroundings. Recruitment started on November 26&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt;, 2019 and is ongoing; the cohort is planned to last at least 30&#8201;months. The healthcare package (including HIV, hepatitis B, and sexually transmitted infection management, pregnancy screening, and contraception) is available both at mobile clinics organized for a quarterly follow-up (10 intervention sites, each site being visited every two weeks) and at a fixed clinic.&lt;/p&gt;
&lt;p&gt;Four waves of data collection were implemented: (i) clinical and safety data; (ii) socio-behavioral questionnaires; (iii) biological data; and (iv) in-depth interviews with female participants. Four additional waves of data collection are scheduled outside the cohort itself: (i) the medical and activity records of Aprosam for the PRINCESSE participants; (ii) the medical records of HIV+ FSW patients not participating in the PRINCESSE cohort, and routinely examined by Aprosam; (iii) in-depth interviews with key informants in the FSW community; and (iv) in-depth interviews with PRINCESSE follow-up actors.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Discussion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The PRINCESSE project is one of the first interventions offering HIV oral PrEP as part of a more global sexual healthcare package targeting both HIV- and HIV+ women. Second, STIs and viral hepatitis B care were offered to all participants, regardless of their willingness to use PrEP. Another innovation is the implementation of mobile clinics for chronic/quarterly care. In terms of research, PRINCESSE is a comprehensive, interdisciplinary project combining clinical, biological, epidemiological, and social specific objectives and outcomes to document the operational challenges of a multidisease program in real-life conditions.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Trial registration&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The PRINCESSE project was registered on the Clinicaltrial.gov website (NCT03985085) on June 13, 2019.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>



</channel>

</rss>
